THBS2 and infection: Based on the fact that TSP-2 (and not TSP-1) is strongly recognized by IgG1 and IgG3 from putative resistant individuals and not by infection-naïve or chronically infected individuals, preclinical studies focused on the development of Sm-TSP-2 [44].